Pediatric Pharmacy
PGY2 Program Purpose: PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.
Description
The University of Oklahoma College of Pharmacy (OUCOP) and OU Health has been accredited with the American Society of Health System Pharmacists (ASHP) since 2005 and currently offers position each year. Our program is approved to offer the traditional PGY2 Pediatric Pharmacy Residency and the PGY2 Pediatric with Added Critical Care Pediatric Specialty Pathway (PSP). In the upcoming academic year, 2025-2026, we are recruiting only for the PGY2 Pediatric with Added Critical Care Pediatric Specialty Pathway.
This one-year position provides the resident with the academic rank of Clinical Instructor with the University of Oklahoma College of Pharmacy (OUCOP). The residents are primarily involved in clinical practice at Oklahoma Children's Hospital at OU Health. Educational responsibilities and training include didactic (lecture) and experiential (rotation) teaching to Pharm.D. students in addition to other activities. Residents contribute to the education of pharmacy students, resident physicians, medical students, faculty physicians, and other members of the healthcare team. PGY2 residents will participate in teaching sessions, deliver at least 2 formal presentations, and serve as preceptor of record for APPE students during one learning experience. PGY2 residents have the option to receive an advanced teaching and precepting skills certificate through completion of additional requirements. In addition, the resident will be required to complete an original research project for completion of the residency program; they will be expected to present their research at national meetings and will be encouraged to publish their findings.
Outcomes
PGY2 Pediatric residents are expected to achieve 80% of these educational outcomes from the required ASHP PGY2 Pediatric Residency competency, areas, goals, and objectives (CAGOS). The remaining 20% must be assessed at a minimum of satisfactory progress. These include the objectives under the five required competency areas (R1-patient care, R2-advancing practice and improving patient care, R3-leadership and management, R4- teaching/education/dissemination of knowledge, RS-management of medical emergencies) as well as the objectives under two of the elective competency areas (E4-added skills for pediatric pharmacy scholarship).
In addition to this, residents are also expected to document coverage of the required pediatric disease states listed at the end of the ASHP Educational Outcomes, Goals, and Objectives for PGY2 Pediatric Pharmacy residents.
Practice Site
The Downtown Campus of OU Health in Oklahoma City is comprised of two hospitals: Oklahoma Children’s Hospital at OU Health and University of Oklahoma Medical Center. Oklahoma Children’s Hospital at OU Health is a 336-bed teaching hospital with a 106-bed Neonatal ICU, a 34-bed Medical ICU, and a 25-bed Cardiovascular ICU (CICU). It is the only comprehensive children's hospital in the state of Oklahoma.
Traditional PGY2 Pediatrics Rotation Requirements (Not recruiting for academic year 2025-2026)
-
Residents are required to complete 12, one-month calendar rotations.
- Orientation
- General Pediatrics I
- General Pediatrics II*
- PICU I
- NICU I
- NICU II
- Hematology/Oncology
- Nephrology/Cardiology
- CICU I
- Research
*During General Pediatrics II, the resident will serve as the primary preceptor for 2 APPE students.
-
Residents select 2 electives
- Clinical toxicology/poison control center
- Infectious disease
- Out-patient hematology/oncology
- Stem cell transplant
- Emergency medicine
- Other*
*May also elect to repeat one to the required rotations as above.
-
Unless other specified below, residents complete these longitudinal rotations from July through June each academic year.
- Research Longitudinal Rotation
- Longitudinal Staffing
- Longitudinal Teaching Rotation
- Longitudinal Ambulatory Care Rotation (1 half-day per week, August-June)
- Pharmacy Practice and Management
Critical Care Pediatric Specialty Pathway Rotation Requirements (Recruiting in academic year 2025-2026)
-
Residents are required to complete 12, one-month calendar rotations.
- Orientation (July)
- General Pediatrics*
- Hematology/Oncology
- PICU I
- NICU I
- NICU II*
- CICU I*
- Research
- Clinical toxicology/poison control
*During one of these core rotations, the resident will serve as the primary preceptor for 2 APPE students under the director of one of our faculty-based preceptors.
-
Residents must complete 2 of the following rotations.
- PICU II
- CICU II
- Emergency Medicine (OCH)
- NICU III
-
Residents must complete 1 additional elective.
- Nephrology
- Stem cell transplant
- Infectious disease
- Out-patient hematology/oncology
- Emergency Medicine [OU Medical Center (OUMC)]
- Other (May also elect to repeat one of the required or critical care selective rotations as above)
-
Unless other specified below, residents complete these longitudinal rotations from July through June each academic year.
- Research Longitudinal Rotation
- Longitudinal Staffing
- Longitudinal Teaching Rotation
- Pharmacy Practice Management
Other Requirements and Opportunities
-
The resident delivers at a minimum of two lectures to Pharm.D. students and other interprofessional learners throughout the year. Teaching also occurs throughout the year as the resident presents interdisciplinary in services to the medical and nursing staff and assists with precepting of Pharm.D. students in the experiential portion of their curriculum. The resident assumes primary precepting responsibility for P4 students during the latter part of the residency.
-
Residents complete a research curriculum which includes the University of Oklahoma Health Sciences Center Institutional Review Board (IRB) certification for conducting human research and specific research training sessions through Resident Rounds. Each resident designs and executes an original research project under the mentorship of their research committee, which consists of the residency program director, an expert in the practice area in which research will be conducted, and an expert in study design, data analysis, and statistical methods. Residents present preliminary research findings during a podium presentation at the Pediatric Pharmacy Association Annual Meeting and the Oklahoma Pharmacy Residency Conference. In accordance with ASHP standards, residents prepare a high-quality manuscript based on their research findings.
-
The resident participates in the peer-review of at least two manuscripts submitted for publication. The resident is also expected to contribute to the literature through preparation and publication of a newsletter article, a case report or review article, and their original research.
-
The resident develops practice management skills through participation in institutional projects and committee work at The Oklahoma Children’s Hospital at OU Health. In addition, the resident develops their leadership philosophy through readings and discussions with the leadership preceptor and one-on-one meetings with local pharmacy leaders.
-
Professional Organization Involvement
Resident involvement in local and national professional organizations (as their residency schedule allows) is encouraged. Examples include:
- Oklahoma Society of Health-System Pharmacists (OSHP)
- American Society of Health-System Pharmacists (ASHP)
- American College of Clinical Pharmacy (ACCP)
- American Association of Colleges of Pharmacy (AACP)
- Pediatric Pharmacy Association (PPA)
University of Oklahoma College of Pharmacy Committees
Resident involvement in college committees is also encouraged. Examples include:
- One academic committee to support the College
- Other meetings based on resident interests
Program Requirements and Checklist
PGY2 Pediatric PSP Critical Care Pharmacy Residency Program Requirements and Checklist
Residency Program Director
Peter N. Johnson, Pharm.D., BCPPS, FPPA, FCCM, FASHP
Professor, Department of Pharmacy: Clinical and Administrative Sciences. Practice area: CICU, PICU (back-up coverage), and inpatient general pediatrics
Residency Program Preceptors
Rachel C. Boardman, Pharm.D., BCCCP, Clinical Pharmacist, OU Medical Center at OU Health. Practice area: Emergency medicine
Whitney Bueno, Pharm.D., Pediatric Clinical Pharmacist and Interim Clinical Pharmacy Manager, Oklahoma Children's Hospital at OU Health. Practice area: Outpatient ambulatory care in hematology and oncology.
Jennifer Dannelley, Pharm.D. Pediatric Clinical Pharmacist, Oklahoma Children’s Hospital at OU Health. Practice area: Outpatient ambulatory care in cystic fibrosis, pulmonology.
Maura Harkin, Pharm.D., BCPPS. Pediatric Clinical Pharmacist, Oklahoma Children’s Hospital at OU Health. Practice area: PICU.
Jennifer Le, Pharm.D., BCPPS. Pediatric Clinical Pharmacist, Oklahoma Children's Hospital at OU Health. Practice area: Inpatient hematology and oncology, stem cell transplant.
Teresa V. Lewis, Pharm.D., BCPS. Associate Professor, Department of Pharmacy: Clinical and Administrative Sciences. Practice area: Nephrology, renal transplant, and inpatient general pediatrics.
Jamie Miller, Pharm.D., BCPPS, FPPA. Professor, Department of Pharmacy: Clinical and Administrative Sciences. Practice area: Neonatology, and inpatient general pediatrics.
Misty Oldham, Pharm.D., BCPS, AAHIVP. Associate Professor, Department of Pharmacy: Clinical and Administrative Sciences. Practice area: Outpatient HIV and inpatient infectious disease.
Eszter Moore, Pharm.D., CSPI. Certified specialist in Poison Information, Oklahoma Poison Center. Practice area: Toxicology.
Avery Parman, Pharm.D., Pediatric Clinical Pharmacist, Oklahoma Children's Hospital at OU Health. Practice area: Emergency medicine.
Katy Stephens, Pharm.D., BCPPS. Pediatric Clinical Pharmacist, Oklahoma Children’s Hospital at OU Health. Practice area: CICU and cardiac transplant.
Current Residents
Natalie Nix, Pharm.D. (2024-2025); PGY1 - Mercy Hospital Northwest Arkansas; Rogers, AR and Doctor of Pharmacy - Medical University of South Carolina; Charleston, SC
Research Project: Evaluation of immune globulin for critically ill children status-post hypogammaglobulinemia status-post cardiac surgery
Residency Program Alumni
Over 25 residents have completed our residency program since the start of the program in the 1980s. Our graduates have developed innovative practice sites and have been influential leaders in the United States and abroad.
Avery Parman, Pharm.D. (2023-2024); Pediatric Clinical Pharmacy Specialist - Emergency medicine, Oklahoma Children's at OU Health; Oklahoma City, OK
Eugenie Chang, Pharm.D. (2022-2023); Pediatric Clinical Pharmacy Specialist, Bethany Children's Health Center; Bethany, OK
Caitlyn Bradford, Pharm.D., BCPPS (2021-2022); Assistant Professor, Department of Clinical Pharmacy, Philadelphia College of Pharmacy at Saint Joseph's University; Philadelphia, PA.
Katy Stephens, Pharm.D., BCPPS (2020-2021). Pediatric Clinical Pharmacy Specialist— CICU and heart transplant, Oklahoma Children’s Hospital at OU Health; Oklahoma City, OK.
Khalid Taher, Pharm.D., BCPS, BCPPS (2020-2021). Pediatric Clinical Pharmacy Specialist—PICU and Emergency Medicine; PGY1 Pharmacy Residency Deputy Director, King Faisal Specialist Hospital, Riyadh, Saudi Arabia.
Maura Harkin, Pharm.D., BCPPS (2019-2020). Pediatric Clinical Pharmacy Specialist—PICU, Oklahoma Children’s Hospital at OU Health; Oklahoma City, OK.
Brittany Powers Shaddix, Pharm.D., BCPPS (2018-2019). Director of Professional Affairs, Alabama Society of Health-System Pharmacists; Birmingham, AL.
Amy Nguyen, Pharm.D., BCPPS (2016-2017). Pediatric Clinical Pharmacy Specialist and PGY1 Pharmacy and PGY2 Pediatrics Residency Program Director, Phoenix Children's Hospital; Phoenix, AZ.
Amanda Capino, Pharm.D., BCPPS (2015-2016). Clinical Associate Professor and Pediatric Clinical Pharmacy Specialist, Marshall University School of Pharmacy, Huntington, WV.
Katlyn (Katie) Hughes, Pharm.D., BCPPS (2014-2015). Clinical Pharmacy Specialist. First Databank, Inc. Indianapolis, IN.
Bethany Ibach, Pharm.D., BCPPS (2013-2014).
Megan Andrews Carroll, Pharm.D. (2012-2013).
Erin (Lammers) Martin, Pharm.D., BCPS, BCPPS (2011-2012), Pediatric Clinical Specialist, Missouri Health Care Women’s and Children’s Hospital; Columbia, MO.
Misty Oldham, Pharm.D., BCPS, AAHIVP (2010-2011), Associate Professor and Pediatric Clinical Pharmacy Specialist - Peds ID and HIV, University of Oklahoma College of Pharmacy; Oklahoma City, OK.
Emily (Gish) Benefield, Pharm.D., BCPS, BCPPS (2009-2010), Inpatient Pharmacy Programs Directory, Seattle Children's Hospital; Seattle, WA.
Brooke (Honey) Gildon, Pharm.D., BCPS, BCPPS, AE-C, FPPA (2008-2009), Professor and Pediatric Clinical Pharmacy Specialist, Southwestern University College of Pharmacy; Oklahoma City, OK.
Jamie Miller, Pharm.D., BCPS, BCPPS, FPPA (2007-2008), Professor, PGY1 Pharmacy Residency Program Director, and Pediatric Clinical Pharmacy Specialist - NICU, University of Oklahoma College of Pharmacy; Oklahoma City, OK.
Teresa V. Lewis, Pharm.D., BCPS (2004-2005), Associate Professor and Pediatric Clinical Pharmacy Specialist - Pediatric nephrology, University of Oklahoma College of Pharmacy; Oklahoma City, OK.
Tracy Hagemann, Pharm.D., FCCP, FPPAG, Associate Dean and Professor, Clinical Pharmacy at the University of Tennessee College of Pharmacy; Nashville, TN.
Kelly Gabeau Martin, Pharm.D., Dallas, TX.
Chad Reynolds, Pharm.D., Vann Healthcare Pharmacy; Glasgow, KY.
Maria Santerio, Pharm.D., Clinical Pharmacist, Central Florida Medical Center; Tampa, FL.
Renee Bellinger, Pharm.D., Associate Professor, University of Incarnate Word; San Antonio, TX.
Bill Maish, Pharm.D.
Cathy Poon, Pharm.D., FPPA, Interim Dean of the School of Health Professions and Professional of Clinical Pharmacy at Philadelphia College of Pharmacy at Saint Joseph's University; Philadelphia, PA.
Accreditation
This residency program is accredited by the American Society of Health-System Pharmacists.